These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25725134)

  • 21. Elucidation of the transport mechanism of baicalin and the influence of a Radix Angelicae Dahuricae extract on the absorption of baicalin in a Caco-2 cell monolayer model.
    Zhu ML; Liang XL; Zhao LJ; Liao ZG; Zhao GW; Cao YC; Zhang J; Luo Y
    J Ethnopharmacol; 2013 Nov; 150(2):553-9. PubMed ID: 24076259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds.
    Yumoto R; Murakami T; Nakamoto Y; Hasegawa R; Nagai J; Takano M
    J Pharmacol Exp Ther; 1999 Apr; 289(1):149-55. PubMed ID: 10086998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The kinetic, mechanistic and cytomorphological effects of palytoxin in human intestinal cells (Caco-2) explain its lower-than-parenteral oral toxicity.
    Fernández DA; Louzao MC; Vilariño N; Espiña B; Fraga M; Vieytes MR; Román A; Poli M; Botana LM
    FEBS J; 2013 Aug; 280(16):3906-19. PubMed ID: 23773601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer.
    Ujhelyi Z; Fenyvesi F; Váradi J; Fehér P; Kiss T; Veszelka S; Deli M; Vecsernyés M; Bácskay I
    Eur J Pharm Sci; 2012 Oct; 47(3):564-73. PubMed ID: 22841998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paracellular calcium transport across Caco-2 and HT29 cell monolayers.
    Blais A; Aymard P; Lacour B
    Pflugers Arch; 1997 Jul; 434(3):300-5. PubMed ID: 9178630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier.
    Moran GW; O'Neill C; McLaughlin JT
    Regul Pept; 2012 Oct; 178(1-3):95-101. PubMed ID: 22809889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Permeability of plumbagin across human intestinal cell in vitro.
    Sumsakul W; Na-Bangchang K
    Arch Pharm Res; 2016 Mar; 39(3):380-9. PubMed ID: 26620575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rhamnolipids enhance epithelial permeability in Caco-2 monolayers.
    Jiang L; Long X; Meng Q
    Int J Pharm; 2013 Mar; 446(1-2):130-5. PubMed ID: 23402975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The evaluation criterions about Caco-2 cell model].
    Ma Y; Li PB; Su WW; Chen DW
    Zhong Yao Cai; 2006 Sep; 29(9):946-8. PubMed ID: 17212055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methadone inhibits rhodamine123 transport in Caco-2 cells.
    Störmer E; Perloff MD; von Moltke LL; Greenblatt DJ
    Drug Metab Dispos; 2001 Jul; 29(7):954-6. PubMed ID: 11408360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential P-glycoprotein-mediated herb-drug interaction of phyllanthin at the intestinal absorptive barrier.
    Dunkoksung W; Vardhanabhuti N; Jianmongkol S
    J Pharm Pharmacol; 2019 Feb; 71(2):213-219. PubMed ID: 30251430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell growing density affects the structural and functional properties of Caco-2 differentiated monolayer.
    Natoli M; Leoni BD; D'Agnano I; D'Onofrio M; Brandi R; Arisi I; Zucco F; Felsani A
    J Cell Physiol; 2011 Jun; 226(6):1531-43. PubMed ID: 20945374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of hyperosmosis on paracellular permeability in Caco-2 cell monolayers.
    Inokuchi H; Takei T; Aikawa K; Shimizu M
    Biosci Biotechnol Biochem; 2009 Feb; 73(2):328-34. PubMed ID: 19202294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers?
    Behrens I; Kissel T
    Eur J Pharm Sci; 2003 Aug; 19(5):433-42. PubMed ID: 12907294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of hr-IL2 treatment on intestinal P-glycoprotein expression and activity in Caco-2 cells.
    Belliard AM; Tardivel S; Farinotti R; Lacour B; Leroy C
    J Pharm Pharmacol; 2002 Aug; 54(8):1103-9. PubMed ID: 12195825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human small intestinal epithelial cells differentiated from adult intestinal stem cells as a novel system for predicting oral drug absorption in humans.
    Takenaka T; Harada N; Kuze J; Chiba M; Iwao T; Matsunaga T
    Drug Metab Dispos; 2014 Nov; 42(11):1947-54. PubMed ID: 25200868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Applications of a 7-day Caco-2 cell model in drug discovery and development.
    Peng Y; Yadava P; Heikkinen AT; Parrott N; Railkar A
    Eur J Pharm Sci; 2014 Jun; 56():120-30. PubMed ID: 24576578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A protocol for differentiation of human intestinal Caco-2 cells in asymmetric serum-containing medium.
    Ferruzza S; Rossi C; Scarino ML; Sambuy Y
    Toxicol In Vitro; 2012 Dec; 26(8):1252-5. PubMed ID: 22265977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dulbecco's modified eagle's medium and minimum essential medium--which one is more preferred for establishment of Caco-2 cell monolayer model used in evaluation of drug absorption?
    Wu XW; Wang RF; Yuan M; Xu W; Yang XW
    Pharmazie; 2013 Oct; 68(10):805-10. PubMed ID: 24273884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copper treatment alters the barrier functions of human intestinal Caco-2 cells: involving tight junctions and P-glycoprotein.
    Liu Z; Chen B
    Hum Exp Toxicol; 2004 Aug; 23(8):369-77. PubMed ID: 15346718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.